Diamond BioFund Inc.(TW:6901)
NT$14.00+0.25 (+1.82%)
TW:6901
Diamond BioFund Inc. financials statements
NT$14.00
At close:+0.25 (+1.82%)
Diamond BioFund Inc. (6901) Ratios
Diamond BioFund Inc. Ratios
TW:6901's free cash flow for Q2 2026 was NT$-15.52M. For the 2026 fiscal year, TW:6901's free cash flow was increased by NT$0.00 and operating cash flow was NT$-15.52M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 112.05 | 24.76 | 146.38 | 74.56 | 51.07 |
| Quick Ratio | 112.05 | 24.76 | 146.38 | 74.56 | 51.07 |
| Cash Ratio | 111.10 | 0.61 | 31.88 | 2.32 | 0.09 |
| Solvency Ratio | -8.32 | -8.26 | -14.32 | 5.62 | 12.41 |
| Operating Cash Flow Ratio | -6.69 | 5.49 | -2.97 | 3.28 | -1.52 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 2.64B | NT$ 4.84B | NT$ 9.48B | NT$ 10.60B | NT$ 9.86B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.01 | 1.03 | 1.01 | 1.01 | 1.02 |
| Debt Service Coverage Ratio | -370.36 | -659.51 | -3192.00 | 3304.06 | 5188.50 |
| Interest Coverage Ratio | -414.04 | -47.98 | -201.28 | -561.58 | -185.56 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.11 | 0.14 | 0.17 | 0.01 | 0.04 |
| Net Debt to EBITDA | 2.33 | 0.00 | 0.77 | -0.37 | 0.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 4794.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 196430.54% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 191735.91% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 214524.66% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 196948.66% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 197102.68% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 197102.68% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.08% | 105.08% | 99.98% | 90.54% | 96.32% |
| EBT Per EBIT | 91.81% | 1325.09% | 1592.67% | -640.41% | -2890.40% |
| Return on Assets (ROA) | -12.55% | -23.59% | -19.81% | 7.13% | 26.84% |
| Return on Equity (ROE) | -12.74% | -24.27% | -20.09% | 7.22% | 27.44% |
| Return on Capital Employed (ROCE) | -13.70% | -1.73% | -1.25% | -1.25% | -0.98% |
| Return on Invested Capital (ROIC) | -13.66% | -1.72% | -1.25% | -1.13% | -0.95% |
| Return on Tangible Assets | -12.55% | -23.59% | -19.81% | 7.13% | 26.84% |
| Earnings Yield | -8.36% | -9.05% | -6.80% | 1.74% | 4.90% |
| Efficiency Ratios | |||||
| Receivables Turnover | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -14524.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | -14524.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | -14524.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.19 | 1.34 | -0.25 | 0.63 | -0.32 |
| Free Cash Flow Per Share | -0.19 | 1.32 | -0.28 | 0.63 | -0.32 |
| Dividend Paid and CapEx Coverage Ratio | -877.90 | 80.00 | -1.34 | 3.11 | 0.00 |
| Capital Expenditure Coverage Ratio | -877.90 | 80.00 | -10.05 | 231.23 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.77 | 9.67 | -1.52 | 128.87 | -7.15 |
| Operating Cash Flow to Sales Ratio | 278.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -1.18% | 4.04% | -0.57% | 1.03% | -0.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -11.96 | -11.05 | -14.70 | 57.29 | 20.37 |
| Price-to-Sales (P/S) Ratio | -23586.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.52 | 2.68 | 2.96 | 4.16 | 5.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -84.63 | 24.73 | -176.85 | 97.51 | -193.58 |
| Price-to-Operating Cash Flow Ratio | -84.72 | 24.41 | -194.11 | 97.09 | -193.58 |
| Price-to-Earnings Growth (PEG) Ratio | 0.22 | 1.02 | 0.04 | -0.89 | -0.40 |
| Enterprise Value Multiple | -9.97 | -11.76 | -14.00 | 51.08 | 19.57 |
| Enterprise Value | 11.39B | 27.80B | 36.04B | 45.60B | 58.18B |
| EV to EBITDA | -9.97 | -11.76 | -14.00 | 51.08 | 19.57 |
| EV to Sales | -19119.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -68.60 | 24.73 | -167.67 | 96.81 | -193.66 |
| EV to Operating Cash Flow | -68.68 | 24.41 | -184.03 | 96.39 | -193.66 |
| Tangible Book Value Per Share | 10.82 | 12.20 | 16.51 | 14.75 | 10.95 |
| Shareholders’ Equity Per Share | 10.82 | 12.20 | 16.51 | 14.75 | 10.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.05 | 0.00 | 0.09 | 0.04 |
| Revenue Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.38 | -2.96 | -3.32 | 1.06 | 3.01 |
| Tax Burden | 1.00 | 1.05 | 1.00 | 0.91 | 0.96 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | -264.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.14 | -0.48 | 0.08 | 0.54 | -0.10 |
Currency in TWD
